Form D · Other Technology
Penelope Health Inc.
Dover, DE · CIK 0002131697
Offering snapshot reported Sep 30, 2026 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2026 | Initial | $24,999,998 | No comparison | 10 | SEC filing |
| Apr 30, 2026 | Initial | $2,725,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599383
Source: Form D, filed Sep 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mattjis Willem De Paepe | Director, Executive, Promoter |
| Mattijs Willem De Paepe | Director, Executive, Promoter |
| Matthew Holt | Director |
| Sohum Piyush Patel | Director, Executive, Promoter |
| Thorsten Wirkes | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1111 B S Governors Ave Ste 55643
Dover, DE, 19904
Dover, DE, 19904